MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PLRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Pliant Therapeutics (PLRX) Ownership - Who owns Pliant Therapeutics?

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
331 Oyster Point Boulevard
Phone
+1 650 481-6770
Employees
49
Web
https://www.pliantrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
71.83M
P/E Ratio
N/A
Total Cash
170.89M
Projected Growth
N/A
Total Debt
28.78M
Revenue
N/A
Risk (Beta)
1.05
Dividend Yield
N/A
Total Cash/Share
2.76
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PLRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PLRX
A.I. Advisor
published General Information

General Information

a company which engages in the business of developing and commercializing novel therapies for fibrotic diseases

Industry Biotechnology

Profile
Details
Industry
N/A
Address
331 Oyster Point Boulevard
Phone
+1 650 481-6770
Employees
49
Web
https://www.pliantrx.com